 | • レポートコード：QY2108PAL8843 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおける止血ジェルの市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、止血ジェルの種類別市場規模（フィブリン、ゼラチン、その他）、用途別市場規模（低侵襲手術、一般外科、その他）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の止血ジェル市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における止血ジェルの種類別市場規模（2016年-2027年）：フィブリン、ゼラチン、その他 ・世界における止血ジェルの用途別市場規模（2016年-2027年）：低侵襲手術、一般外科、その他 ・止血ジェルの中国市場分析 - 止血ジェルの中国市場規模（2016年-2027年） - 中国における止血ジェルの主要プレイヤー別市場シェア - 中国における止血ジェルの種類別市場規模：フィブリン、ゼラチン、その他 - 中国における止血ジェルの用途別市場規模：低侵襲手術、一般外科、その他 ・止血ジェルの北米市場（2016年-2027年） ・止血ジェルのヨーロッパ市場（2016年-2027年） ・止血ジェルのアジア太平洋市場（2016年-2027年） ・止血ジェルの中南米市場（2016年-2027年） ・止血ジェルの中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Baxter、J&J、CryoLife、Integra Life Sciences、Advance Medical Solution、BD、CSL Behring、Pfizer、B Braun ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Hemostatic gel is used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.In recent years, global hemostatic gels have developed rapidly, with an average growth rate of around 7%.In 2018, global production of hemostatic gels was about 3.26 million pieces.In 2018, China accounted for about 3 percent of global sales.In the next five years, China’s hemostatic gel products will continue to grow rapidly.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Baxter, J&J, CryoLife, Integra Life Sciences are major suppliers.These suppliers have mastered key technologies and patents, and have a fixed customer base, which has formed a monopoly situation in the market.The growth of the elderly population and the increasing prevalence of chronic diseases are the driving factors affecting the industry.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually led to surgery, which in turn spurred the development of the hemostatic gel industry.
Global Hemostatic Gel key players include Baxter, J&J, Advance Medical Solution, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share over 60%, followed by Europe, with a share over 20 percent.
In terms of product, Fibrin is the largest segment, with a share over 35%. And in terms of application, the largest application is Minimally Invasive Surgery, followed by General Surgery, etc.
Market Analysis and Insights: Global and China Hemostatic Gel Market
This report focuses on global and China Hemostatic Gel market.
In 2020, the global Hemostatic Gel market size was US$ 900.5 million and it is expected to reach US$ 1284.1 million by the end of 2027, with a CAGR of 5.2% during 2021-2027. In China the Hemostatic Gel market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Hemostatic Gel Scope and Market Size
Hemostatic Gel market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Hemostatic Gel market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Hemostatic Gel market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Fibrin
Gelatin
Other
Segment by Application
Minimally Invasive Surgery
General Surgery
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Baxter
J&J
CryoLife
Integra Life Sciences
Advance Medical Solution
BD
CSL Behring
Pfizer
B Braun
1 Study Coverage
1.1 Hemostatic Gel Product Introduction
1.2 Market by Type
1.2.1 Global Hemostatic Gel Market Size Growth Rate by Type
1.2.2 Fibrin
1.2.3 Gelatin
1.2.4 Other
1.3 Market by Application
1.3.1 Global Hemostatic Gel Market Size Growth Rate by Application
1.3.2 Minimally Invasive Surgery
1.3.3 General Surgery
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hemostatic Gel Market Size, Estimates and Forecasts
2.1.1 Global Hemostatic Gel Revenue 2016-2027
2.1.2 Global Hemostatic Gel Sales 2016-2027
2.2 Global Hemostatic Gel, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Hemostatic Gel Historical Market Size by Region (2016-2021)
2.3.1 Global Hemostatic Gel Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Hemostatic Gel Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Hemostatic Gel Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Hemostatic Gel Sales Forecast by Region (2022-2027)
2.4.2 Global Hemostatic Gel Revenue Forecast by Region (2022-2027)
3 Global Hemostatic Gel Competitor Landscape by Players
3.1 Global Top Hemostatic Gel Manufacturers by Sales
3.1.1 Global Hemostatic Gel Sales by Manufacturer (2016-2021)
3.1.2 Global Hemostatic Gel Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Hemostatic Gel Manufacturers by Revenue
3.2.1 Key Hemostatic Gel Manufacturers Covered: Ranking by Revenue
3.2.2 Global Hemostatic Gel Revenue by Manufacturers (2016-2021)
3.2.3 Global Hemostatic Gel Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Hemostatic Gel Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Hemostatic Gel Revenue in 2020
3.2.6 Global Hemostatic Gel Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Hemostatic Gel Price by Manufacturers
3.4 Global Hemostatic Gel Manufacturing Base Distribution, Product Types
3.4.1 Hemostatic Gel Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hemostatic Gel Product Type
3.4.3 Date of International Manufacturers Enter into Hemostatic Gel Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Hemostatic Gel Market Size by Type (2016-2021)
4.1.1 Global Hemostatic Gel Sales by Type (2016-2021)
4.1.2 Global Hemostatic Gel Revenue by Type (2016-2021)
4.1.3 Hemostatic Gel Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Hemostatic Gel Market Size Forecast by Type (2022-2027)
4.2.1 Global Hemostatic Gel Sales Forecast by Type (2022-2027)
4.2.2 Global Hemostatic Gel Revenue Forecast by Type (2022-2027)
4.2.3 Hemostatic Gel Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Hemostatic Gel Market Size by Application (2016-2021)
5.1.1 Global Hemostatic Gel Sales by Application (2016-2021)
5.1.2 Global Hemostatic Gel Revenue by Application (2016-2021)
5.1.3 Hemostatic Gel Price by Application (2016-2021)
5.2 Hemostatic Gel Market Size Forecast by Application (2022-2027)
5.2.1 Global Hemostatic Gel Sales Forecast by Application (2022-2027)
5.2.2 Global Hemostatic Gel Revenue Forecast by Application (2022-2027)
5.2.3 Global Hemostatic Gel Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Hemostatic Gel Market Size YoY Growth 2016-2027
6.1.1 China Hemostatic Gel Sales YoY Growth 2016-2027
6.1.2 China Hemostatic Gel Revenue YoY Growth 2016-2027
6.1.3 China Hemostatic Gel Market Share in Global Market 2016-2027
6.2 China Hemostatic Gel Market Size by Players (International and Local Players)
6.2.1 China Top Hemostatic Gel Players by Sales (2016-2021)
6.2.2 China Top Hemostatic Gel Players by Revenue (2016-2021)
6.3 China Hemostatic Gel Historic Market Review by Type (2016-2021)
6.3.1 China Hemostatic Gel Sales Market Share by Type (2016-2021)
6.3.2 China Hemostatic Gel Revenue Market Share by Type (2016-2021)
6.3.3 China Hemostatic Gel Price by Type (2016-2021)
6.4 China Hemostatic Gel Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Hemostatic Gel Sales Forecast by Type (2022-2027)
6.4.2 China Hemostatic Gel Revenue Forecast by Type (2022-2027)
6.4.3 China Hemostatic Gel Price Forecast by Type (2022-2027)
6.5 China Hemostatic Gel Historic Market Review by Application (2016-2021)
6.5.1 China Hemostatic Gel Sales Market Share by Application (2016-2021)
6.5.2 China Hemostatic Gel Revenue Market Share by Application (2016-2021)
6.5.3 China Hemostatic Gel Price by Application (2016-2021)
6.6 China Hemostatic Gel Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Hemostatic Gel Sales Forecast by Application (2022-2027)
6.6.2 China Hemostatic Gel Revenue Forecast by Application (2022-2027)
6.6.3 China Hemostatic Gel Price Forecast by Application (2022-2027)
7 North America
7.1 North America Hemostatic Gel Market Size YoY Growth 2016-2027
7.2 North America Hemostatic Gel Market Facts & Figures by Country
7.2.1 North America Hemostatic Gel Sales by Country (2016-2021)
7.2.2 North America Hemostatic Gel Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Hemostatic Gel Market Size YoY Growth 2016-2027
8.2 Asia Pacific Hemostatic Gel Market Facts & Figures by Region
8.2.1 Asia Pacific Hemostatic Gel Sales by Region (2016-2021)
8.2.2 Asia Pacific Hemostatic Gel Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Hemostatic Gel Market Size YoY Growth 2016-2027
9.2 Europe Hemostatic Gel Market Facts & Figures by Country
9.2.1 Europe Hemostatic Gel Sales by Country (2016-2021)
9.2.2 Europe Hemostatic Gel Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Hemostatic Gel Market Size YoY Growth 2016-2027
10.2 Latin America Hemostatic Gel Market Facts & Figures by Country
10.2.1 Latin America Hemostatic Gel Sales by Country (2016-2021)
10.2.2 Latin America Hemostatic Gel Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Hemostatic Gel Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Hemostatic Gel Market Facts & Figures by Country
11.2.1 Middle East and Africa Hemostatic Gel Sales by Country (2016-2021)
11.2.2 Middle East and Africa Hemostatic Gel Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Baxter
12.1.1 Baxter Corporation Information
12.1.2 Baxter Description and Business Overview
12.1.3 Baxter Hemostatic Gel Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Baxter Hemostatic Gel Products Offered
12.1.5 Baxter Recent Development
12.2 J&J
12.2.1 J&J Corporation Information
12.2.2 J&J Description and Business Overview
12.2.3 J&J Hemostatic Gel Sales, Revenue and Gross Margin (2016-2021)
12.2.4 J&J Hemostatic Gel Products Offered
12.2.5 J&J Recent Development
12.3 CryoLife
12.3.1 CryoLife Corporation Information
12.3.2 CryoLife Description and Business Overview
12.3.3 CryoLife Hemostatic Gel Sales, Revenue and Gross Margin (2016-2021)
12.3.4 CryoLife Hemostatic Gel Products Offered
12.3.5 CryoLife Recent Development
12.4 Integra Life Sciences
12.4.1 Integra Life Sciences Corporation Information
12.4.2 Integra Life Sciences Description and Business Overview
12.4.3 Integra Life Sciences Hemostatic Gel Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Integra Life Sciences Hemostatic Gel Products Offered
12.4.5 Integra Life Sciences Recent Development
12.5 Advance Medical Solution
12.5.1 Advance Medical Solution Corporation Information
12.5.2 Advance Medical Solution Description and Business Overview
12.5.3 Advance Medical Solution Hemostatic Gel Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Advance Medical Solution Hemostatic Gel Products Offered
12.5.5 Advance Medical Solution Recent Development
12.6 BD
12.6.1 BD Corporation Information
12.6.2 BD Description and Business Overview
12.6.3 BD Hemostatic Gel Sales, Revenue and Gross Margin (2016-2021)
12.6.4 BD Hemostatic Gel Products Offered
12.6.5 BD Recent Development
12.7 CSL Behring
12.7.1 CSL Behring Corporation Information
12.7.2 CSL Behring Description and Business Overview
12.7.3 CSL Behring Hemostatic Gel Sales, Revenue and Gross Margin (2016-2021)
12.7.4 CSL Behring Hemostatic Gel Products Offered
12.7.5 CSL Behring Recent Development
12.8 Pfizer
12.8.1 Pfizer Corporation Information
12.8.2 Pfizer Description and Business Overview
12.8.3 Pfizer Hemostatic Gel Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Pfizer Hemostatic Gel Products Offered
12.8.5 Pfizer Recent Development
12.9 B Braun
12.9.1 B Braun Corporation Information
12.9.2 B Braun Description and Business Overview
12.9.3 B Braun Hemostatic Gel Sales, Revenue and Gross Margin (2016-2021)
12.9.4 B Braun Hemostatic Gel Products Offered
12.9.5 B Braun Recent Development
12.11 Baxter
12.11.1 Baxter Corporation Information
12.11.2 Baxter Description and Business Overview
12.11.3 Baxter Hemostatic Gel Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Baxter Hemostatic Gel Products Offered
12.11.5 Baxter Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Hemostatic Gel Industry Trends
13.2 Hemostatic Gel Market Drivers
13.3 Hemostatic Gel Market Challenges
13.4 Hemostatic Gel Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hemostatic Gel Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Hemostatic Gel Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Fibrin
Table 3. Major Manufacturers of Gelatin
Table 4. Major Manufacturers of Other
Table 5. Global Hemostatic Gel Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 6. Global Hemostatic Gel Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Hemostatic Gel Sales by Regions (2016-2021) & (K Units)
Table 8. Global Hemostatic Gel Sales Market Share by Regions (2016-2021)
Table 9. Global Hemostatic Gel Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Hemostatic Gel Sales Forecast by Region (2022-2027) & (K Units)
Table 11. Global Hemostatic Gel Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Hemostatic Gel Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Hemostatic Gel Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Hemostatic Gel Sales by Manufacturers (2016-2021) (K Units)
Table 15. Global Hemostatic Gel Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Hemostatic Gel Manufacturers by Revenue (US$ Million) in 2020
Table 17. Hemostatic Gel Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Hemostatic Gel Revenue Share by Manufacturers (2016-2021)
Table 19. Global Hemostatic Gel Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Hemostatic Gel by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemostatic Gel as of 2020)
Table 21. Key Manufacturers Hemostatic Gel Price (2016-2021) (US$/Unit)
Table 22. Hemostatic Gel Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Hemostatic Gel Product Type
Table 24. Date of International Manufacturers Enter into Hemostatic Gel Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Hemostatic Gel Sales by Type (2016-2021) (K Units)
Table 27. Global Hemostatic Gel Sales Share by Type (2016-2021)
Table 28. Global Hemostatic Gel Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Hemostatic Gel Revenue Share by Type (2016-2021)
Table 30. Hemostatic Gel Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 31. Global Hemostatic Gel Sales Forecast by Type (2022-2027) & (K Units)
Table 32. Global Hemostatic Gel Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Hemostatic Gel Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Hemostatic Gel Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Hemostatic Gel Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 36. Global Hemostatic Gel Sales by Application (2016-2021) (K Units)
Table 37. Global Hemostatic Gel Sales Share by Application (2016-2021)
Table 38. Global Hemostatic Gel Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Hemostatic Gel Revenue Share by Application (2016-2021)
Table 40. Hemostatic Gel Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 41. Global Hemostatic Gel Sales Forecast by Application (2022-2027) & (K Units)
Table 42. Global Hemostatic Gel Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Hemostatic Gel Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Hemostatic Gel Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Hemostatic Gel Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 46. China Hemostatic Gel Sales (K Units) of Key Companies (2016-2021)
Table 47. China Hemostatic Gel Sales Share by Company (2016-2021)
Table 48. China Hemostatic Gel Revenue (US$ Million) by Company (2016-2021)
Table 49. China Hemostatic Gel Revenue Share by Company (2016-2021)
Table 50. China Hemostatic Gel Sales (K Units) by Type (2016-2021)
Table 51. China Hemostatic Gel Sales Share by Type (2016-2021)
Table 52. China Hemostatic Gel Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Hemostatic Gel Price (US$/Unit) by Type (2016-2021)
Table 54. China Hemostatic Gel Sales (K Units) by Type (2022-2027)
Table 55. China Hemostatic Gel Sales Share by Type (2022-2027)
Table 56. China Hemostatic Gel Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Hemostatic Gel Revenue Share by Type (2022-2027)
Table 58. China Hemostatic Gel Price (US$/Unit) by Type (2022-2027)
Table 59. China Hemostatic Gel Sales (K Units) by Application (2016-2021)
Table 60. China Hemostatic Gel Sales Share by Application (2016-2021)
Table 61. China Hemostatic Gel Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Hemostatic Gel Price (US$/Unit) by Application (2016-2021)
Table 63. China Hemostatic Gel Sales (K Units) by Application (2022-2027)
Table 64. China Hemostatic Gel Sales Share by Application (2022-2027)
Table 65. China Hemostatic Gel Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Hemostatic Gel Revenue Share by Application (2022-2027)
Table 67. China Hemostatic Gel Price (US$/Unit) by Application (2022-2027)
Table 68. North America Hemostatic Gel Sales by Country (2016-2021) & (K Units)
Table 69. North America Hemostatic Gel Sales Market Share by Country (2016-2021)
Table 70. North America Hemostatic Gel Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Hemostatic Gel Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Hemostatic Gel Sales by Region (2016-2021) & (K Units)
Table 73. Asia Pacific Hemostatic Gel Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Hemostatic Gel Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Hemostatic Gel Revenue Market Share by Region (2016-2021)
Table 76. Europe Hemostatic Gel Sales by Country (2016-2021) & (K Units)
Table 77. Europe Hemostatic Gel Sales Market Share by Country (2016-2021)
Table 78. Europe Hemostatic Gel Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Hemostatic Gel Revenue Market Share by Country (2016-2021)
Table 80. Latin America Hemostatic Gel Sales by Country (2016-2021) & (K Units)
Table 81. Latin America Hemostatic Gel Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Hemostatic Gel Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Hemostatic Gel Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Hemostatic Gel Sales by Country (2016-2021) & (K Units)
Table 85. Middle East and Africa Hemostatic Gel Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Hemostatic Gel Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Hemostatic Gel Revenue Market Share by Country (2016-2021)
Table 88. Baxter Corporation Information
Table 89. Baxter Description and Business Overview
Table 90. Baxter Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Baxter Hemostatic Gel Product
Table 92. Baxter Recent Development
Table 93. J&J Corporation Information
Table 94. J&J Description and Business Overview
Table 95. J&J Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. J&J Product
Table 97. J&J Recent Development
Table 98. CryoLife Corporation Information
Table 99. CryoLife Description and Business Overview
Table 100. CryoLife Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. CryoLife Product
Table 102. CryoLife Recent Development
Table 103. Integra Life Sciences Corporation Information
Table 104. Integra Life Sciences Description and Business Overview
Table 105. Integra Life Sciences Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Integra Life Sciences Product
Table 107. Integra Life Sciences Recent Development
Table 108. Advance Medical Solution Corporation Information
Table 109. Advance Medical Solution Description and Business Overview
Table 110. Advance Medical Solution Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Advance Medical Solution Product
Table 112. Advance Medical Solution Recent Development
Table 113. BD Corporation Information
Table 114. BD Description and Business Overview
Table 115. BD Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. BD Product
Table 117. BD Recent Development
Table 118. CSL Behring Corporation Information
Table 119. CSL Behring Description and Business Overview
Table 120. CSL Behring Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. CSL Behring Product
Table 122. CSL Behring Recent Development
Table 123. Pfizer Corporation Information
Table 124. Pfizer Description and Business Overview
Table 125. Pfizer Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Pfizer Product
Table 127. Pfizer Recent Development
Table 128. B Braun Corporation Information
Table 129. B Braun Description and Business Overview
Table 130. B Braun Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. B Braun Product
Table 132. B Braun Recent Development
Table 133. Hemostatic Gel Market Trends
Table 134. Hemostatic Gel Market Drivers
Table 135. Hemostatic Gel Market Challenges
Table 136. Hemostatic Gel Market Restraints
Table 137. Hemostatic Gel Customers List
Table 138. Hemostatic Gel Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemostatic Gel Product Picture
Figure 2. Global Hemostatic Gel Sales Market Share by Type in 2020 & 2027
Figure 3. Fibrin Product Picture
Figure 4. Gelatin Product Picture
Figure 5. Other Product Picture
Figure 6. Global Hemostatic Gel Sales Market Share by Application in 2020 & 2027
Figure 7. Minimally Invasive Surgery
Figure 8. General Surgery
Figure 9. Others
Figure 10. Hemostatic Gel Report Years Considered
Figure 11. Global Hemostatic Gel Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Hemostatic Gel Market Size 2016-2027 (US$ Million)
Figure 13. Global Hemostatic Gel Sales 2016-2027 (K Units)
Figure 14. Global Hemostatic Gel Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Hemostatic Gel Sales Market Share by Region (2016-2021)
Figure 16. Global Hemostatic Gel Sales Market Share by Region in 2020
Figure 17. Global Hemostatic Gel Revenue Market Share by Region (2016-2021)
Figure 18. Global Hemostatic Gel Revenue Market Share by Region in 2020
Figure 19. Global Hemostatic Gel Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Hemostatic Gel Revenue in 2020
Figure 21. Hemostatic Gel Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Hemostatic Gel Sales Market Share by Type (2016-2021)
Figure 23. Global Hemostatic Gel Sales Market Share by Type in 2020
Figure 24. Global Hemostatic Gel Revenue Market Share by Type (2016-2021)
Figure 25. Global Hemostatic Gel Revenue Market Share by Type in 2020
Figure 26. Global Hemostatic Gel Sales Market Share by Application (2016-2021)
Figure 27. Global Hemostatic Gel Sales Market Share by Application in 2020
Figure 28. Global Hemostatic Gel Revenue Market Share by Application (2016-2021)
Figure 29. Global Hemostatic Gel Revenue Market Share by Application in 2020
Figure 30. China Hemostatic Gel Sales Growth Rate 2016-2027 (K Units)
Figure 31. China Hemostatic Gel Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. China Hemostatic Gel Market Share in Global Market 2016-2027
Figure 33. China 5 and 10 Largest Hemostatic Gel Players Market Share by Revenue in Hemostatic Gel in 2020
Figure 34. China Hemostatic Gel Revenue Share by Type (2016-2021)
Figure 35. China Hemostatic Gel Revenue Growth Rate by Type in 2016 & 2020
Figure 36. China Hemostatic Gel Revenue Share by Application (2016-2021)
Figure 37. China Hemostatic Gel Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Hemostatic Gel Sales Growth Rate 2016-2021 (K Units)
Figure 39. North America Hemostatic Gel Revenue Growth Rate 2016-2021 (US$ Million)
Figure 40. North America Hemostatic Gel Sales Market Share by Country in 2020
Figure 41. North America Hemostatic Gel Revenue Market Share by Country in 2020
Figure 42. U.S. Hemostatic Gel Sales Growth Rate (2016-2021) (K Units)
Figure 43. U.S. Hemostatic Gel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Canada Hemostatic Gel Sales Growth Rate (2016-2021) (K Units)
Figure 45. Canada Hemostatic Gel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Europe Hemostatic Gel Sales Growth Rate 2016-2021 (K Units)
Figure 47. Europe Hemostatic Gel Revenue Growth Rate 2016-2021 (US$ Million)
Figure 48. Europe Hemostatic Gel Sales Market Share by Country in 2020
Figure 49. Europe Hemostatic Gel Revenue Market Share by Country in 2020
Figure 50. Germany Hemostatic Gel Sales Growth Rate (2016-2021) (K Units)
Figure 51. Germany Hemostatic Gel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. France Hemostatic Gel Sales Growth Rate (2016-2021) (K Units)
Figure 53. France Hemostatic Gel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. U.K. Hemostatic Gel Sales Growth Rate (2016-2021) (K Units)
Figure 55. U.K. Hemostatic Gel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Italy Hemostatic Gel Sales Growth Rate (2016-2021) (K Units)
Figure 57. Italy Hemostatic Gel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Russia Hemostatic Gel Sales Growth Rate (2016-2021) (K Units)
Figure 59. Russia Hemostatic Gel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Asia Pacific Hemostatic Gel Sales Growth Rate 2016-2021 (K Units)
Figure 61. Asia Pacific Hemostatic Gel Revenue Growth Rate 2016-2021 (US$ Million)
Figure 62. Asia Pacific Hemostatic Gel Sales Market Share by Region in 2020
Figure 63. Asia Pacific Hemostatic Gel Revenue Market Share by Region in 2020
Figure 64. China Hemostatic Gel Sales Growth Rate (2016-2021) (K Units)
Figure 65. China Hemostatic Gel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Japan Hemostatic Gel Sales Growth Rate (2016-2021) (K Units)
Figure 67. Japan Hemostatic Gel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. South Korea Hemostatic Gel Sales Growth Rate (2016-2021) (K Units)
Figure 69. South Korea Hemostatic Gel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. India Hemostatic Gel Sales Growth Rate (2016-2021) (K Units)
Figure 71. India Hemostatic Gel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Australia Hemostatic Gel Sales Growth Rate (2016-2021) (K Units)
Figure 73. Australia Hemostatic Gel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. China Taiwan Hemostatic Gel Sales Growth Rate (2016-2021) (K Units)
Figure 75. China Taiwan Hemostatic Gel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Indonesia Hemostatic Gel Sales Growth Rate (2016-2021) (K Units)
Figure 77. Indonesia Hemostatic Gel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Thailand Hemostatic Gel Sales Growth Rate (2016-2021) (K Units)
Figure 79. Thailand Hemostatic Gel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Malaysia Hemostatic Gel Sales Growth Rate (2016-2021) (K Units)
Figure 81. Malaysia Hemostatic Gel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Latin America Hemostatic Gel Sales Growth Rate 2016-2021 (K Units)
Figure 83. Latin America Hemostatic Gel Revenue Growth Rate 2016-2021 (US$ Million)
Figure 84. Latin America Hemostatic Gel Sales Market Share by Country in 2020
Figure 85. Latin America Hemostatic Gel Revenue Market Share by Country in 2020
Figure 86. Mexico Hemostatic Gel Sales Growth Rate (2016-2021) (K Units)
Figure 87. Mexico Hemostatic Gel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Brazil Hemostatic Gel Sales Growth Rate (2016-2021) (K Units)
Figure 89. Brazil Hemostatic Gel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Argentina Hemostatic Gel Sales Growth Rate (2016-2021) (K Units)
Figure 91. Argentina Hemostatic Gel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Middle East and Africa Hemostatic Gel Sales Growth Rate 2016-2021 (K Units)
Figure 93. Middle East and Africa Hemostatic Gel Revenue Growth Rate 2016-2021 (US$ Million)
Figure 94. Middle East and Africa Hemostatic Gel Sales Market Share by Country in 2020
Figure 95. Middle East and Africa Hemostatic Gel Revenue Market Share by Country in 2020
Figure 96. Turkey Hemostatic Gel Sales Growth Rate (2016-2021) (K Units)
Figure 97. Turkey Hemostatic Gel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 98. Saudi Arabia Hemostatic Gel Sales Growth Rate (2016-2021) (K Units)
Figure 99. Saudi Arabia Hemostatic Gel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. UAE Hemostatic Gel Sales Growth Rate (2016-2021) (K Units)
Figure 101. UAE Hemostatic Gel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. Hemostatic Gel Value Chain
Figure 103. Channels of Distribution
Figure 104. Distributors Profiles
Figure 105. Bottom-up and Top-down Approaches for This Report
Figure 106. Data Triangulation
Figure 107. Key Executives Interviewed
止血剤・組織封止剤の世界及び中国市場 Hemostasis is defined as "the blocking of bleeding or bleeding through blood vessels or other parts of the body".Hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.The industry is driven by a growing base of…- 止血剤の世界及び中国市場 Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. The world's leading manufacturers of hemostatics are Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Soluti…
- 止血鉗子の世界市場 2020年 Market Overview The Hemostatic Forceps market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 止血アナライザーの世界市場 2020年 Market Overview The global Hemostatic Analyzer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hemostatic Analyzer marke…
- 低侵襲手術用装置の世界及び中国市場 Minimally invasive procedures (also known as minimally invasive surgeries) have been enabled by the advance of various medical technologies. Surgery by definition is invasive and many operations requiring incisions of some size are referred to as open surgery. Global Minimally Invasive Surgery Devic…